Barclays raised the firm’s price target on Clorox (CLX) to $139 from $137 and keeps an Underweight rating on the shares. The firm says the earnings report “felt similar to previous quarters in many regards.”
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CLX:
- Clorox CEO: We entered the fiscal year with strong momentum
- Clorox Company Reports Strong Q1 2025 Financial Results
- Closing Bell Movers: Microsoft, Meta both down about 3% despite earnings beats
- Clorox Sees Strong Q1 Growth Post-Cyberattack Recovery
- Clorox reports Q1 adjusted EPS $1.86, consensus $1.39